Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (24)

2024

  1. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2022

  1. Time to Consider the “Exposome Hypothesis” in the Development of the Obesity Pandemic

    Nutrients, Vol. 14, Núm. 8

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  3. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

  4. Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: A prospective cohort study

    Journal of Headache and Pain, Vol. 21, Núm. 1

2018

  1. Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

    Nature Medicine, Vol. 24, Núm. 12, pp. 1899-1909

2017

  1. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

    The Lancet Neurology, Vol. 16, Núm. 3, pp. 238-250

  2. Obesity and the nervous system: more questions

    The Lancet Neurology

2016

  1. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 3, pp. 335-343

2015

  1. Aberrant mitochondria in a bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the Collagen VI α2(VI) chain

    Journal of Biological Chemistry, Vol. 290, Núm. 7, pp. 4272-4281

2013

  1. Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson's disease

    Experimental Brain Research, Vol. 226, Núm. 3, pp. 451-462

  2. Clinical phenotypes within non-surgical patients with mesial temporal lobe epilepsy caused by hippocampal sclerosis based on response to antiepileptic drugs

    Seizure, Vol. 22, Núm. 1, pp. 20-23

  3. Obstructive sleep apnea severity is associated with left ventricular mass independent of other cardiovascular risk factors in morbid obesity

    Journal of Clinical Sleep Medicine, Vol. 9, Núm. 11, pp. 1165-1171

2012

  1. Variant Creutzfeldt-Jakob disease occurring in mother and son

    Journal of Neurology, Neurosurgery and Psychiatry

2011

  1. Carotid intima-media thickness changes with Mediterranean diet: A randomized trial (PREDIMED-Navarra)

    Atherosclerosis, Vol. 219, Núm. 1, pp. 158-162

  2. LINGO1 gene analysis in Parkinson's disease phenotypes

    Movement Disorders, Vol. 26, Núm. 4, pp. 722-727

2010

  1. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease

    Nature Reviews Neuroscience, Vol. 11, Núm. 11, pp. 760-772

  2. Missing pieces in the Parkinson's disease puzzle

    Nature Medicine, Vol. 16, Núm. 6, pp. 653-661

  3. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463